| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 | Feb 22, 2023 | Enliven Therapeutics, Inc. | CFO | Sell | 46.3 | -9,856 | -26.31% | ✗ | $46K |
| Jan 30, 2023 | Feb 1, 2023 | Enliven Therapeutics, Inc. | CFO | Sell | 46.3 | -3,596 | -8.76% | ✗ | $14.1K |
| Dec 11, 2020 | Dec 15, 2020 | Enliven Therapeutics, Inc. | CFO | Sell | 13.8 | -1,250 | -100.00% | ✓ | $31.3K |
| Nov 12, 2013 | Nov 12, 2013 | CURIS INC | CFO | Buy | 91.3 | +10,000 | 10.28% | ✗ | $28.6K |
| May 6, 2013 | May 7, 2013 | CURIS INC | CFO | Sell | 22.5 | -33,309 | -24.43% | ✗ | $120.9K |
| Sep 18, 2012 | Sep 21, 2012 | CURIS INC | CFO | Sell | 15.0 | -26,250 | -23.26% | ✓ | $112.4K |
| Apr 18, 2012 | Apr 20, 2012 | CURIS INC | CFO | Sell | 20.0 | -42,844 | -19.83% | ✓ | $214.6K |
| Jan 10, 2005 | Jan 12, 2005 | CURIS INC | CFO | Sell | 26.3 | -10,000 | -100.00% | ✗ | $46.2K |
| Dec 8, 2004 | Dec 10, 2004 | CURIS INC | CFO | Sell | 26.3 | -10,000 | -100.00% | ✗ | $49.7K |
| Dec 2, 2004 | Dec 6, 2004 | CURIS INC | CFO | Sell | 22.5 | -18,107 | -100.00% | ✗ | $81.7K |
| Sep 13, 2004 | Sep 14, 2004 | CURIS INC | CFO | Sell | 22.5 | -11,250 | -100.00% | ✗ | $51.2K |